S100B-RAGE-Mediated Augmentation of Angiotensin II-Induced Activation of JAK2 in Vascular Smooth Muscle Cells Is Dependent on PLD2
- 1 September 2003
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 52 (9) , 2381-2388
- https://doi.org/10.2337/diabetes.52.9.2381
Abstract
Angiotensin II (Ang II), a vasoactive peptide that is also considered a growth factor, has been implicated in both normal and diabetic cellular proliferation. We recently found that activation of janus kinase 2 (JAK2) is essential for the Ang II–induced proliferation of vascular smooth muscle cells (VSMCs) and that high glucose augments Ang II–induced proliferation of VSMCs by increasing signal transduction through activation of JAK2. Here, we demonstrate that S100B, a ligand for the receptor of advanced glycation end products (RAGEs), augmented both Ang II–induced tyrosine phosphorylation of JAK2 and cell proliferation in VSMCs in a receptor-dependent manner. We also found that S100B-RAGE interaction triggered intracellular generation of reactive oxygen species (ROS), VSMC proliferation, and JAK2 tyrosine phosphorylation via activation of phospholipase D (PLD)2. These results provide direct evidence for linkages between PLD2, ROS production, and S100B-RAGE–induced enhancement of Ang II–induced cell proliferation and activation of JAK2 in VSMCs.Keywords
This publication has 30 references indexed in Scilit:
- Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucoseKidney International, 2002
- Roles for βII-Protein Kinase C and RACK1 in Positive and Negative Signaling for Superoxide Anion Generation in Differentiated HL60 CellsPublished by Elsevier ,2001
- Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucoseKidney International, 2000
- Pyridoxamine, an Inhibitor of Advanced Glycation Reactions, Also Inhibits Advanced Lipoxidation ReactionsPublished by Elsevier ,2000
- Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro.Journal of Clinical Investigation, 1998
- Diabetes, advanced glycation endproducts and vascular diseaseVascular Medicine, 1998
- Angiotensin Receptors and Their AntagonistsNew England Journal of Medicine, 1996
- Diabetes Mellitus and Associated Hypertension, Vascular Disease, and NephropathyHypertension, 1995
- Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptorNature, 1995
- Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell linesJournal of Immunological Methods, 1993